Primary information |
---|
sequence ID | Seq_2505 |
Peptide sequence | GANGAPGNDGAKGDAGAPGAPGSQGAPG |
CancerPDF_ID | CancerPDF_ID10917, |
PMID | 21805675 |
Protein Name | Collagen alpha-1(I) chain |
UniprotKB Entry Name | CO1A1_HUMAN |
Fluid | Urine |
M/Z | 2340.023 |
Profiling Technique | MALDI-TOF |
Peptide Identification technique | MALDI-TOF-MS |
Labelled/Label Free | Label Free |
FDR | 1 |
CancerPDF_ID | CancerPDF_ID10917, |
p-Value | NA |
Software | NA |
Length | 28 |
Cancer Type | Muscle-invasive bladder cancer |
Database | SwissProt Database |
Modification | "Oxidation: 6, 18, 21, 27" |
Number of Patients | 751 bladder cancer and 127 control |
Regulation | Differentially expressed between cancer vs normal samples |
Validation | Mann-Whitney tests and areas under receiver-operator characteristic |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
Peptide Atlas | NA |
IEDB | NA |
Primary information |
---|
sequence ID | Seq_2506 |
Peptide sequence | GANGApGNDGAKGDAGApGApGSQGApG |
CancerPDF_ID | CancerPDF_ID3736, |
PMID | 27026199 |
Protein Name | Collagen alpha-1(I) chain |
UniprotKB Entry Name | CO1A1_HUMAN |
Fluid | Urine |
fdr | 2339 |
Profiling Technique | "CE-MS, Micro-TOF-MS" |
Peptide Identification technique | MS-MS |
Labelled/Label Free | Label Free |
CancerPDF_ID | CancerPDF_ID3736, |
p-Value | less than 0.05 |
Software | Proteome Discoverer 1.2 |
Length | 28 |
Cancer Type | Bladder cancer |
Database | Uniprot Human non-redundant Database |
Modification | p:Hydroxy-Proline |
Number of Patients | 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls) |
Regulation | Differentially expressed between recurrence of UBC vs recurrence control |
Validation | Independent Validation |
Sensitivity | For testing dataset 88% |
Specificity | For testing dataset 51% |
Accuracy | NA |
Peptide Atlas | NA |
IEDB | NA |